Cited by

• 2018Health systems development in Thailand: a solid platform for successful implementation of universal health coverage379 cited
• 2017Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending287 cited
• 2017The path to longer and healthier lives for all Africans by 2030: the Lancet Commission on the future of health in sub-Saharan Africa244 cited
• 2020Enhancing global access to cancer medicines205 cited
• 2017How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? Lessons Learned from European Countries203 cited
• 2021Psychotropic medicine consumption in 65 countries and regions, 2008–19: a longitudinal study202 cited
• 2023Challenges to the Availability and Affordability of Essential Medicines in African Countries: A Scoping Review201 cited
• 2019The costs of diabetes treatment in low- and middle-income countries: a systematic review198 cited
• 2021Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey180 cited
• 2022The availability, cost, and affordability of essential medicines for asthma and COPD in low-income and middle-income countries: a systematic review170 cited
• 2017Addressing the challenge of high-priced prescription drugs in the era of precision medicine: A systematic review of drug life cycles, therapeutic drug markets and regulatory frameworks143 cited
• 2019Access to medicines through health systems in low- and middle-income countries139 cited
• 2019Comparison of essential medicines lists in 137 countries124 cited
• 2017Universal Health Coverage and Essential Packages of Care110 cited
• 2022Revisiting the issue of access to medicines in Africa: Challenges and recommendations109 cited
• 2017High adherence to the ‘Wise List’ treatment recommendations in Stockholm: a 15-year retrospective review of a multifaceted approach promoting rational use of medicines104 cited